NCT00231777
- Conditions
- Pathological Conditions, Signs and Symptoms, Post-operative Nausea and Vomiting, Signs and Symptoms, +2 more
- Locations
-
Not specified
Clinical trial condition
Vomiting
Explore clinical trials studying Vomiting. Study availability and eligibility vary by location and protocol.
542 public trials
47 recruiting studies
Vomiting trial results
NCT01189292
- Conditions
- Endocrine System Diseases, Nausea, Pathologic Processes, +8 more
- Locations
-
- Department of Surgery Sankt Gallen, Switzerland
NCT00954941
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT02116257
- Conditions
- Nausea, PONV, Pathologic Processes, +7 more
- Locations
-
- Severance Hospital Seoul, South Korea
Completed
Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting
NCT02473887
- Conditions
- Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +4 more
- Locations
-
Not specified
NCT00372970
- Conditions
- Digestive System Diseases, Dyspepsia, Gastrointestinal Diseases, +9 more
- Locations
-
- Temple University Hospital Philadelphia, Pennsylvania, United States
NCT00211601
- Conditions
- Chemotherapy Induced Nausea and Vomiting, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +2 more
- Locations
-
Not specified
NCT01074697
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
- Locations
-
- RAH Cancer Centre, Royal Adelaide Hospital Adelaide SA, Australia
- Department of Oncology Aarhus, Denmark
- Rigshospitalet, Finsen Centret Copenhagen, Denmark
- Herlev Hospital Herlev, Denmark
NCT01074255
- Conditions
- Chemotherapy-induced Nausea and Vomiting, Nausea, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
Not specified
NCT00104403
- Conditions
- Chemotherapy-induced Nausea and Vomiting, Nausea, Nausea and Vomiting, Chemotherapy-Induced, +4 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Corona, California, United States
- GSK Investigational Site Greenbrae, California, United States
- GSK Investigational Site Loma Linda, California, United States